Changing infant mortality: the need to spend more while getting less.
A steady decline of infant and maternal mortality has been recorded for as long as these statistics have been collected. Much of the improvement has been due to reductions in infectious diseases and to social, economic, and public health improvements over the years. The major portion of mortality reductions took place before there were any important effects of medical care. However, there is increasing evidence suggesting that important benefits, can still be gained from medical technology. But, with infant mortality at low levels (between 7 and 12/1,000 live births in high-income countries) the wide use of high technology to effect further reductions guarantees escalating medical care expenditures. With pressures mounting to control costs, what will society be willing to give up in order to make this care available? From where will funds come to utilize costly existing and new medical technology so that all expectant mothers and newborns needing it may have essentially unlimited access in order to reap potential benefits?
D003365:Costs and Cost Analysis; D004470:Economics, Medical; D006295:Health Resources / Q000600:supply & distribution*; D006801:Humans; D007223:Infant; D007224:Infant Care; D007226:Infant Mortality; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal / Q000191:economics; D013677:Medical Laboratory Science / Q000191:economics; D012106:Research; D014481:United States